Cook Jennifer E.'s Form 4 filing
BridgeBio Pharma, Inc. (BBIO) · filed Jun 24, 2026
- Accession no.
- 0001470831-26-000636
- Filed
- Jun 24, 2026
- Trade date
- Jun 22-24, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.75M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cook Jennifer E.CIK 0001754371 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | AGrant or awardAcquired | +3,990 | $0.00F2 | $0 | 10,579 | Direct | |
| Jun 23, 2026 | Common Stock | SSaleDisposed | −2,196 | $68.57 | −$150,579.72 | 8,383 | Direct | |
| Jun 24, 2026 | Common Stock | MOption exerciseAcquired | +20,000 | $8.45 | +$169,000 | 28,383 | Direct | |
| Jun 24, 2026 | Common Stock | MOption exerciseAcquired | +17,167 | $16.75 | +$287,547.25 | 45,550 | Direct | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −37,167 | $70.00 | −$2,601,690 | 8,383 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | AGrant or awardAcquired | +5,277 | $0.00 | $0 | 5,277 | Direct | |
| Jun 24, 2026 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 19,000 | Direct | |
| Jun 24, 2026 | Common Stock | MOption exerciseDisposed | −17,167 | $0.00 | $0 | 17,167 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.